ArticleThe Journal of biological chemistry2026
Extracellular ATP drives tryptophan metabolism and aryl hydrocarbon receptor activation to promote cellular senescence.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
We have shown that extracellular ATP promotes senescence through the activation of the P2Y11 receptor (P2Y11R). The underlying molecular mechanisms remain to be fully established. Synthesis of tryptophan (Trp)-derived indole metabolites is mediated mostly by the gut microbiota. Trp metabolites can activate the aryl hydrocarbon receptor (AhR). Whether eukaryotic cells can generate Trp-derived indoles and their functional significance remains to be fully established. Here, we investigated the role of Trp metabolites and AhR activation in purinergic-mediated senescence of human fibroblasts. We find that ATP activated AhR in a P2Y11R-dependent manner and that AhR activation was necessary for ATP-induced senescence. Stimulation with an AhR agonist was sufficient to induce senescence. Interestingly, depletion of Trp in the conditioned medium inhibited ATP-induced senescence. We show that ATP stimulation upregulated the expression of the L-amino acid oxidase interleukin-4-induced-1, which has been shown to metabolize Trp into indole-3-pyruvate (I3P), in a P2Y11R-dependent fashion. We find that I3P-derived Trp metabolites are upregulated in ATP-induced senescent human fibroblasts and that stimulation with I3P and I3P-derived Trp metabolites was sufficient to promote senescence in these cells. In addition, I3P stimulation activated AhR, and AhR inhibition impaired I3P-induced senescence. Downregulation of interleukin-4-induced-1 inhibited ATP-induced AhR activation and senescence. Finally, we show that conditioned medium derived from senescent lung fibroblasts, which were induced to senesce by I3P treatment, promoted the proliferation of breast cancer cells and their tumorigenic potential. Our study identifies the existence of a novel purinergic dependent signaling pathway that functionally couples Trp metabolism to the development of a premature senescent phenotype in human fibroblasts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.